Bioinformatics software platform Ziliomics seeded by FACIT
Ziliomics Inc, a Toronto bioinformatics software startup, has raised undisclosed seed-stage financing. The Prospects Oncology Fund of Fight Against Cancer Innovation Trust (FACIT) was the investor. Created by FACIT, Ziliomics is developing web-based, modular software solutions to help physicians make treatment decisions for patients living with cancer. The proceeds of the seed round will advance the development of Heliotrope, the company's lead product, and position Ziliomics for partnerships and additional funding. FACIT, established by the Ontario Institute for Cancer Research, launched the Prospects Oncology Fund last year.
28 June 2018•3 mins read
